arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Exagen Inc.

XGN Health Care Medical Specialities
$7.48
▲ +0.9% Today
as of Oct 22, 16:53 ET
Last 30 days +1.77% Sep 14 → Oct 22
$7.24 $7.64 $8.04 $8.45 $8.85 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$7.72
High
$7.82
Low
$7.25
Volume
$219,091
Avg Vol
$384,137
Mkt Cap
$201M
P/E (TTM)
—
Beta
—
52w High
$12.23
52w Low
$2.59
Div Yield
—
Shares Out
$24M

Recent Press Releases & News last 60 days · 1 item

XGN earnings at a glance

Exagen Inc. (XGN) is scheduled to report earnings on Tuesday, November 3, 2026 — in 11 days. Analysts expect earnings per share of -$0.19, compared with -$0.19 in the same quarter last year (+0%). The options market is pricing a move of about ±29.3% after the report, a range of roughly $5.29 to $9.67 from today's $7.48. Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±17.3% on average; after the most recent report on Aug 4, 2026 it moved +37.8%. That means options currently expect more movement than XGN has typically delivered. XGN beat the consensus EPS estimate in 2 of its last 6 reported quarters. Implied volatility is currently 222%. The share price of $7.48 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.59
$12
51% of range
Avg surprise (last 6)
+2.4%
Avg reaction (last 6)
+13.0%
67% positive
Latest IV / EM
222%
EM ±29.3% · $8 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.44$-0.36$-0.29$-0.21$-0.13 Actual $-0.44Actual $-0.28Actual $-0.31Actual $-0.19Actual $-0.16Actual $-0.28Actual $-0.20Est $-0.20Actual $-0.18Est $-0.18Actual $-0.19Est $-0.13Actual $-0.20Est $-0.20Actual $-0.17Est $-0.24Actual $-0.13Est $-0.19 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-7M$-80,738$7M$14M$21M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Aug 4, 2026Jun/2026 $-0.13 $-0.19 +31.6% -5.6% +37.8% earnings
Mon May 11, 2026Mar/2026 $-0.17 $-0.24 +29.2% +15.0% +34.9% earnings
Tue Mar 10, 20268K 2026-03-10 $-0.20 $-0.20 0.0% — -3.8% earnings
Tue Nov 4, 2025Sep/2025 $-0.19 $-0.13 -46.1% — -9.0% earnings
Tue Jul 29, 2025Jun/2025 $-0.18 $-0.18 0.0% — +14.3% earnings
Mon May 5, 2025Mar/2025 $-0.20 $-0.20 0.0% — +3.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.28 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.16 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.19 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.31 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.28 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.44 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Nov 3, 2026Sep/2026OTHER -$0.19-$0.19 0.0%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$20M$17M—$17M$17M$15M—$13M
Cost of revenue$8M$7M—$7M$7M$6M—$6M
Gross profit$12M$10M—$10M$10M$9M—$7M
Operating income$-2M$-3M—$-3M$-3M$-3M—$-5M
Net income$-3M$-4M—$-7M$-4M$-4M—$-5M
EPS (diluted)$-0.13$-0.17—$-0.31$-0.21$-0.20—$-0.28

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$25M$22M$32M$36M$30M$11M$22M$22M
Inventory————————
Total current assets$43M$44M$49M$53M$51M$33M$36M$36M
Total assets$52M$52M$58M$63M$59M$40M$45M$44M
Long-term debt$22M$22M$22M$22M$22M$18M$20M$20M
Total liabilities$40M$38M$41M$45M$38M$34M$35M$31M
Total equity$12M$14M$17M$18M$21M$6M$10M$13M

Implied volatility — last 90 days

51%489%927%1365%1802% Jun 09 — IV 250% · EM ±31.3%Jun 10 — IV 596% · EM ±70.4%Jun 19 — IV 309% · EM ±68.3%Jun 22 — IV 163% · EM ±33.9%Jun 30 — IV 69% · EM ±11.8%Jul 02 — IV 157% · EM ±25.3%Jul 03 — IV 162% · EM ±25.3%Jul 07 — IV 103% · EM ±13.5%Jul 10 — IV 315% · EM ±34.8%Jul 16 — IV 1803% · EM ±75.3%Jul 20 — IV 244% · EM ±57.7%Jul 21 — IV 115% · EM ±26.7%Jul 28 — IV 340% · EM ±69.7%Jul 29 — IV 339% · EM ±67.8%Aug 04 — IV 351% · EM ±60.4%Aug 05 — IV 334% · EM ±55.7%Aug 06 — IV 350% · EM ±56.6%Aug 12 — IV 430% · EM ±53.9%Aug 13 — IV 475% · EM ±56.1%Aug 14 — IV 469% · EM ±51.8%Aug 17 — IV 322% · EM ±26.9%Aug 24 — IV 88% · EM ±18.3%Aug 25 — IV 140% · EM ±28.7%Aug 26 — IV 142% · EM ±28.4%Aug 27 — IV 143% · EM ±27.9%Aug 28 — IV 152% · EM ±29.1%Aug 31 — IV 158% · EM ±27.9%Sep 01 — IV 98% · EM ±16.9%Sep 02 — IV 155% · EM ±26.0%Sep 03 — IV 154% · EM ±24.9%Sep 04 — IV 228% · EM ±35.6%Sep 07 — IV 257% · EM ±35.6%Sep 08 — IV 104% · EM ±13.7%Sep 09 — IV 304% · EM ±38.1%Sep 10 — IV 340% · EM ±40.2%Sep 11 — IV 154% · EM ±17.1%Sep 14 — IV 432% · EM ±36.1%Sep 15 — IV 461% · EM ±33.4%Sep 21 — IV 100% · EM ±20.9%Sep 22 — IV 101% · EM ±20.6%Sep 23 — IV 105% · EM ±21.1%Sep 24 — IV 102% · EM ±20.0%Sep 25 — IV 154% · EM ±29.5%Sep 28 — IV 110% · EM ±19.5%Sep 29 — IV 121% · EM ±20.8%Sep 30 — IV 52% · EM ±8.6%Oct 01 — IV 55% · EM ±8.9%Oct 02 — IV 117% · EM ±18.4%Oct 06 — IV 222% · EM ±29.3%

Sector peers

XGN earnings FAQ

When is XGN's next earnings date?

Exagen Inc. is expected to report on November 3, 2026.

What is XGN's expected move for earnings?

Options currently price a move of about ±29.3%, or $2.19 per share either way from $7.48.

How does XGN stock usually react to earnings?

Across the last 6 reports the average next-day move was ±17.3%, up 4 times and down 2 times.

What EPS are analysts expecting from Exagen Inc.?

The consensus estimate is -$0.19 per share, versus -$0.19 a year ago.

What is XGN's implied volatility?

XGN's at-the-money implied volatility is about 222% based on the latest options snapshot.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.